Reading about longevity funding at 55

I saw the headline about NewLimit raising another large round of funding for epigenetic reprogramming. It’s hard not to have a mixed reaction to that kind of news. On one hand, the science is interesting. On the other, it all feels very far away.

That money is for a future that might arrive in ten or twenty years. Meanwhile, my longevity protocol is happening right now, three times a week, at a powerlifting gym. My goal isn’t cellular rejuvenation in a dish; it’s getting my deadlift to 300 pounds before I turn 57 and maintaining the bone density to not break a hip if I fall when I’m 75. Muscle is the organ of longevity we can actually train today, and the evidence for its role in metabolic health and functional lifespan is overwhelming.

It feels like there’s a disconnect. We chase these futuristic cures while the basics, especially for women my age, are still treated like afterthoughts. The research on HRT is still recovering from the WHI fallout, leaving us to figure out dosing and delivery methods on our own. We’re the